Discussion paper: dual effects of tumor antigens: induction of tumor resistance or tumor growth enhancement.
TA3-HA nonspecific tumors growing in ascites form shed their membrane components into the ascites fluid. This product can induce tumor growth enhancement if given together with or after i.p. tumor inoculation in relatively large quantities, but if given i.m. in small quantities, several days before tumor challenge, the mice show an elevated resistance to the tumor. The strictly strain-specific TA3-St line does not release such membrane components into the ascites fluid. It has also been found that the TA3-HA cells have a larger membrane fluidity than the TA3-St cells, as measured by membrane microviscosity, using the Shinitzki procedure. Isolation and gross chemical analysis of the TA3-Ha ascites fluid component was carried out. Results, so far, indicate that the active site of this product is probably carbohydrate in nature. The possible mode of action of such component in tumor growth enhancement is most probably by overwhelming and neutralizing immunocytes capable of recognition and eventually cytotoxic action.
D000818:Animals; D000951:Antigens, Neoplasm / Q000008:administration & dosage / Q000032:analysis; D001202:Ascitic Fluid / Q000276:immunology; D002855:Chromatography, Thin Layer; D004247:DNA / Q000096:biosynthesis; D004589:Electrophoresis, Disc; D007108:Immune Tolerance; D007136:Immunoglobulins / Q000032:analysis; D008213:Lymphocyte Activation; D008566:Membranes / Q000276:immunology / Q000502:physiology; D051379:Mice; D008815:Mice, Inbred Strains; D009374:Neoplasms, Experimental / Q000276:immunology* / Q000473:pathology; D010504:Periodic Acid; D013154:Spleen / Q000276:immunology / Q000378:metabolism; D014783:Viscosity
D000951:Antigens, Neoplasm; D007136:Immunoglobulins; D010504:Periodic Acid; D004247:DNA